EA200501633A1 - Новые полиморфные формы оланзапина гидрохлорида - Google Patents

Новые полиморфные формы оланзапина гидрохлорида

Info

Publication number
EA200501633A1
EA200501633A1 EA200501633A EA200501633A EA200501633A1 EA 200501633 A1 EA200501633 A1 EA 200501633A1 EA 200501633 A EA200501633 A EA 200501633A EA 200501633 A EA200501633 A EA 200501633A EA 200501633 A1 EA200501633 A1 EA 200501633A1
Authority
EA
Eurasian Patent Office
Prior art keywords
polymorphic forms
new polymorphic
hydrochloride
olanzapine
new
Prior art date
Application number
EA200501633A
Other languages
English (en)
Other versions
EA008376B1 (ru
Inventor
Янош Пето
Йожеф Баркоци
Петер Котаи Надь
Дьюла Шимиг
Жужа Сент-Кирайи
Original Assignee
Эгиш Дьёдьсердьяр Рт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эгиш Дьёдьсердьяр Рт. filed Critical Эгиш Дьёдьсердьяр Рт.
Publication of EA200501633A1 publication Critical patent/EA200501633A1/ru
Publication of EA008376B1 publication Critical patent/EA008376B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к новым кристаллическим формам I, II и III 2-метил-4-(4-метилпиперазин-1-ил)-10H-тиено-[2,3-b][1,5]-бензодиазепина гидрохлорида, способу их получения и содержащим их фармацевтическим композициям. Эти новые полиморфные формы полезны в качестве активных ингредиентов при лечении психотических состояний.
EA200501633A 2003-04-22 2004-04-22 Новые полиморфные формы оланзапина гидрохлорида EA008376B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0301082A HU226410B1 (en) 2003-04-22 2003-04-22 Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
PCT/HU2004/000042 WO2004094433A1 (en) 2003-04-22 2004-04-22 New polymorphs of olanzapine hydrochloride

Publications (2)

Publication Number Publication Date
EA200501633A1 true EA200501633A1 (ru) 2006-04-28
EA008376B1 EA008376B1 (ru) 2007-04-27

Family

ID=89981318

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501633A EA008376B1 (ru) 2003-04-22 2004-04-22 Новые полиморфные формы оланзапина гидрохлорида

Country Status (24)

Country Link
US (1) US7951798B2 (ru)
EP (1) EP1620439B1 (ru)
JP (1) JP4763594B2 (ru)
KR (1) KR20060004954A (ru)
CN (2) CN101468999B (ru)
AT (1) ATE401332T1 (ru)
AU (1) AU2004232544B2 (ru)
BG (1) BG109361A (ru)
CA (1) CA2522734C (ru)
CZ (1) CZ2005684A3 (ru)
DE (1) DE602004015096D1 (ru)
DK (1) DK1620439T3 (ru)
EA (1) EA008376B1 (ru)
ES (1) ES2310728T3 (ru)
HR (1) HRP20080479T3 (ru)
HU (1) HU226410B1 (ru)
IL (1) IL171522A (ru)
PL (2) PL1620439T3 (ru)
PT (1) PT1620439E (ru)
SI (1) SI1620439T1 (ru)
SK (1) SK50942005A3 (ru)
UA (1) UA80881C2 (ru)
WO (1) WO2004094433A1 (ru)
ZA (1) ZA200508936B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004058773A1 (en) * 2002-12-24 2004-07-15 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
SI21850A (sl) * 2004-07-28 2006-02-28 Krka, Tovarna Zdravil, D.D., Novo Mesto Soli olanzapina in njihova pretvorba v prosto bazo olanzapina
US7910577B2 (en) * 2004-11-16 2011-03-22 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
HUP0501046A2 (en) 2005-11-11 2007-08-28 Egis Gyogyszergyar Nyilvanosan Process for the preparation of olanzapine
KR20090045233A (ko) 2006-07-10 2009-05-07 파이온 유케이 리미티드 속효형 벤조디아제핀 염 및 이의 중합체 형태
WO2008151430A1 (en) * 2007-06-14 2008-12-18 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
US20090286294A1 (en) * 2008-04-04 2009-11-19 University Of Massachusetts Methods and Compositions for Improving the Production of Fuels in Microorganisms
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
RS57207B1 (sr) * 2011-07-08 2018-07-31 Lilly Co Eli Jedinjenja (tieno[2,3-b][1,5]benzoksazepin-4-il)piperazin-1-ila kao dvostruko delujući h1 inverzni agonisti/5-ht2a antagonisti
EP2943498B1 (en) * 2013-01-14 2017-09-06 Eli Lilly and Company (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity h1 inverse agonists/5-ht2a antagonists
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
KR101489062B1 (ko) * 2013-03-28 2015-02-02 동아에스티 주식회사 고순도의 올란자핀 및 이의 결정형 ii의 제조방법
JP6940866B2 (ja) * 2017-06-21 2021-09-29 国立研究開発法人情報通信研究機構 半導体光デバイス、半導体光源、光集積回路、及び半導体光デバイスの製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
CZ300725B6 (cs) * 1997-09-30 2009-07-29 Eli Lilly And Company 2-Methylthienbenzodiazepinová formulace
EA002580B1 (ru) * 1998-09-30 2002-06-27 Эли Лилли Энд Компани Готовая препаративная форма 2-метил-тиено-бензодиазепина
UA80095C2 (en) * 2001-07-20 2007-08-27 Lilly Co Eli 2 methyl-thieno-benzodiazepine lyophilized formulation and method for the preparation thereof
WO2005070938A1 (en) * 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine

Also Published As

Publication number Publication date
CA2522734A1 (en) 2004-11-04
HUP0301082A2 (hu) 2004-12-28
EP1620439B1 (en) 2008-07-16
HRP20080479T3 (en) 2008-10-31
US7951798B2 (en) 2011-05-31
CN100471859C (zh) 2009-03-25
PL378061A1 (pl) 2006-02-20
SK50942005A3 (sk) 2006-02-02
ATE401332T1 (de) 2008-08-15
ES2310728T3 (es) 2009-01-16
CA2522734C (en) 2010-05-25
PL1620439T3 (pl) 2009-02-27
CN101468999B (zh) 2012-05-09
SI1620439T1 (sl) 2009-06-30
KR20060004954A (ko) 2006-01-16
IL171522A (en) 2010-05-31
HU0301082D0 (en) 2003-06-28
EA008376B1 (ru) 2007-04-27
DE602004015096D1 (de) 2008-08-28
JP2006524219A (ja) 2006-10-26
UA80881C2 (en) 2007-11-12
EP1620439A1 (en) 2006-02-01
AU2004232544A1 (en) 2004-11-04
JP4763594B2 (ja) 2011-08-31
DK1620439T3 (da) 2008-11-17
PT1620439E (pt) 2008-10-23
WO2004094433A1 (en) 2004-11-04
AU2004232544B2 (en) 2010-06-03
CN101468999A (zh) 2009-07-01
ZA200508936B (en) 2008-07-30
BG109361A (bg) 2006-09-29
CN1777613A (zh) 2006-05-24
US20070004706A1 (en) 2007-01-04
HU226410B1 (en) 2008-11-28
CZ2005684A3 (cs) 2006-01-11

Similar Documents

Publication Publication Date Title
EA200501633A1 (ru) Новые полиморфные формы оланзапина гидрохлорида
AR002719A1 (es) Forma ii polimorfa 2-metil-4-(4-metil-1-piperacinil)-10h-tieno[2,3-b]-[1,5] benzodiacepina(olanzapina) y formulaciones farmaceuticas que las contienen.
DE602004007239D1 (de) 4-AMINOTHIENOÄ2,3-dÜ PYRIMIDIN -6-CARBONITRIL-DERIVATIVE ZUR VERWENDUNG ALS PDE7 INHIBITOREN
ZA200504238B (en) Thieno[3,2-b]pyridine-6-carbonitriles and thienoo[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
DE60230327D1 (de) Polymorphe von clopidogrel-hydrogensulfat
EA200600064A1 (ru) Производные тиенопиридона как ингибиторы киназ
CY1110832T1 (el) ΠΑΡΑΓΩΓΑ ΠΥΡΡΟΛΟ[3,4-c]ΠΥΡΑΖΟΛΙΟΥ ΔΡΑΣΤΙΚΑ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΤΗΣ ΚΙΝΑΣΗΣ
IL172419A0 (en) Piperazine derivatives and methods of use
EA200601418A1 (ru) ПРОИЗВОДНЫЕ 1Н-ТИЕНО [2,3-с] ПИРАЗОЛА, ПРЕДНАЗНАЧЕННЫЕ ДЛЯ ИСПОЛЬЗОВАНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗЫ
TW200745137A (en) Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
BG108868A (en) Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds
DE60336226D1 (de) Verfahren zur herstellung von olanzapin form i
MXPA05013210A (es) Benzo[b]tiofenos cicloalquilsulfanil-sustituidos como agentes terapeuticos.
MXPA05012953A (es) Benzo[b]tiofenos 3-arilsulfanil y 3-heteroarilsulfanil sustituidos como agentes terapeuticos.
ECSP066932A (es) Formas polimórficas de hidrobromuro acetato de metil(+)-(s)- alfa-(2-clorofenil)-6,7-dihidrotieno[3,2-c]piridina-5(4h), hidrobromuro de clopidogrel
IS6437A (is) Ný setin pýrazóló [4,3-e]díazepín lyfjasamsetningar sem innihalda þau, notkun sem læknandi afurðir og aðferðir við framleiðslu þeirra
HUP0401157A2 (hu) Liofilizált metil-tieno-benzodiazepin készítmény, előállítása és alkalmazása
ATE281455T1 (de) Oxindolderivate
EA200801043A1 (ru) Способ получения оланзапина
SE0100295D0 (sv) New compounds
ATE513834T1 (de) Verfahren zur herstellung von (s)-(+)- clopidogrelbase und deren salzen
SE0303451D0 (sv) New compounds
DK1392698T3 (da) Fremgangsmåde til fremstilling af 6-aryl-4H-s-triazolo-[3,4-c]thieno[2,3-e]-1,4-diazepiner
TR200402843T4 (tr) 6-aril-4H-S-triazolo[3,4,-C]-tiyeno[2,3-E]-1,4-diazepinlerin üretilmesine yönelik yöntem.
TH78308B (th) อนุพันธ์ของเฮทเทอโรไซคลิคไพราโซลที่ทำปฏิกิริยารวมตัวแล้วในฐานะที่เป็นสารยับยั้งไคเนส

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): KG TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ MD RU